1-4 of 4
Amy Stark
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Initial Results of the Phase 2 Treatment Naive Cohort in a Phase 1b/2 Study of Obinutuzumab, Ibrutinib, and Venetoclax in Chronic Lymphocytic Leukemia

Kerry A. Rogers, MD, Ying Huang, MA, MS, Amy Stark, MAS, Farrukh T. Awan, MD MS, Kami J. Maddocks, MD, Jennifer A. Woyach, MD, Thomas Whitlow, BA, John C. Byrd, MD, Jeffrey A. Jones, MD MPH, MBA
Journal: Blood
Blood (2017) 130 (Supplement 1): 431.
https://doi.org/10.1182/blood.V130.Suppl_1.431.431
Published: 2017
Journal Articles

Externally Validated Predictive Clinical Model For Untreated Del(17p13.1) Chronic Lymphocytic Leukemia Patients

Deborah M Stephens, DO, Amy Stark, MAS, William G. Wierda, MD, PhD, Jeffrey A. Jones, MD, MPH, Jennifer A. Woyach, MD, Kami Maddocks, Samantha M. Jaglowski, MD, MPH, Leslie A Andritsos, MD, Joseph M. M. Flynn, DO, MPH, Michael R. Grever, MD, Gerard Lozanski, MD, Constantine S Tam, MBBS, FRACP, FRCPA, MD, Susan O'Brien, MD, Michael J. Keating, MD, Natarajan Muthusamy, DVM, Ph.D, Lynne V. Abruzzo, MD, PhD, Nyla A. Heerema, PhD, John C. Byrd, MD
Journal: Blood
Blood (2013) 122 (21): 4128.
https://doi.org/10.1182/blood.V122.21.4128.4128
Published: 2013
Journal Articles

Changing The Treatment Paradigm For Previously Treated Chronic Lymphocytic Leukemia Patients With Del(17p) Karyotype

Deborah M Stephens, DO, Amy Stark, MAS, Jeffrey A. Jones, MD, MPH, Jennifer A. Woyach, MD, Kami Maddocks, Samantha M. Jaglowski, MD, MPH, Leslie A. Andritsos, MD, Joseph M. M. Flynn, DO, MPH, Michael R. Grever, MD, Gerard Lozanski, MD, Amy J. Johnson, PhD, Natarajan Muthusamy, DVM, Ph.D, Nyla A. Heerema, PhD, John C. Byrd, MD
Journal: Blood
Blood (2013) 122 (21): 2872.
https://doi.org/10.1182/blood.V122.21.2872.2872
Published: 2013
Journal Articles

Alemtuzumab Consolidation Does Not Improve Outcome for CLL Patients with High Risk Genomic Features on Successive CALGB Trials.

Jeffrey A. Jones, MD, MPH, Amy Stark, MAS, Weiqiang Zhao, MD PhD, Thomas S. Lin, MD, PhD, Kanti R Rai, MD, Guido Marcucci, MD, Bercedis Peterson, PhD, MS, Richard A. Larson, MD, Nyla A. Heerema, PhD, John C. Byrd, MD
Journal: Blood
Blood (2011) 118 (21): 1791.
https://doi.org/10.1182/blood.V118.21.1791.1791
Published: 2011